| Prevalence of statin intolerance: a meta-analysis I Bytyci, PE Penson, DP Mikhailidis, ND Wong, AV Hernandez, ... European heart journal 43 (34), 3213-3223, 2022 | 316 | 2022 |
| The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis B Sosnowska, M Mazidi, P Penson, A Gluba-Brzózka, J Rysz, M Banach Atherosclerosis 265, 275-282, 2017 | 188 | 2017 |
| Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis T Gjuladin-Hellon, IG Davies, P Penson, R Amiri Baghbadorani Nutrition reviews 77 (3), 161-180, 2019 | 145 | 2019 |
| LDL-C: lower is better for longer—even at low risk PE Penson, M Pirro, M Banach BMC medicine 18, 1-6, 2020 | 121 | 2020 |
| The role of nutraceuticals in the prevention of cardiovascular disease B Sosnowska, P Penson, M Banach Cardiovascular diagnosis and therapy 7 (Suppl 1), S21, 2017 | 120 | 2017 |
| Inclisiran—new hope in the management of lipid disorders? K Dyrbuś, M Gąsior, P Penson, KK Ray, M Banach Journal of clinical lipidology 14 (1), 16-27, 2020 | 118 | 2020 |
| Introducing the ‘Drucebo’effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label … PE Penson, GBJ Mancini, PP Toth, SS Martin, GF Watts, A Sahebkar, ... Journal of Cachexia, Sarcopenia and Muscle 9 (6), 1023-1033, 2018 | 117* | 2018 |
| The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) F Zhubi-Bakija, G Bajraktari, I Bytyçi, DP Mikhailidis, MY Henein, ... Clinical nutrition 40 (1), 255-276, 2021 | 105 | 2021 |
| Statin-induced nitric oxide signaling: mechanisms and therapeutic implications AM Gorabi, N Kiaie, S Hajighasemi, M Banach, PE Penson, ... Journal of clinical medicine 8 (12), 2051, 2019 | 104 | 2019 |
| The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis SM Maierean, MC Serban, A Sahebkar, S Ursoniu, A Serban, P Penson, ... Journal of clinical lipidology 11 (6), 1393-1406, 2017 | 97* | 2017 |
| Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) M Banach, PE Penson, M Vrablik, M Bunc, K Dyrbus, J Fedacko, D Gaita, ... Pharmacological research 166, 105499, 2021 | 96* | 2021 |
| Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials M Dinca, MC Serban, A Sahebkar, DP Mikhailidis, PP Toth, SS Martin, ... Pharmacol Res 107, 360-71, 2016 | 95* | 2016 |
| Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical … PE Penson, DL Long, G Howard, PP Toth, P Muntner, VJ Howard, ... European Heart Journal 39 (40), 3641-3653, 2018 | 93 | 2018 |
| The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis M Banach, J Lewek, S Surma, PE Penson, A Sahebkar, SS Martin, ... European journal of preventive cardiology 30 (18), 1975-1985, 2023 | 86 | 2023 |
| Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic M Banach, PE Penson, Z Fras, M Vrablik, D Pella, Ž Reiner, SM Nabavi, ... Pharmacological research 158, 104891, 2020 | 85* | 2020 |
| Intake of caffeine and its association with physical and mental health status among university students in Bahrain H Jahrami, M Al-Mutarid, PE Penson, M Al-Islam Faris, Z Saif, L Hammad Foods 9 (4), 473, 2020 | 85 | 2020 |
| Association of types of dietary fats and all-cause and cause-specific mortality: a prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants M Mazidi, DP Mikhailidis, N Sattar, PP Toth, S Judd, MJ Blaha, ... Clinical Nutrition 39 (12), 3677-3686, 2020 | 71 | 2020 |
| Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022) M Banach, S Surma, Z Reiner, N Katsiki, PE Penson, Z Fras, A Sahebkar, ... Cardiovascular Diabetology 21 (1), 263, 2022 | 69 | 2022 |
| What do we know about the role of lipoprotein (a) in atherogenesis 57 years after its discovery? B Cybulska, L Kłosiewicz-Latoszek, PE Penson, M Banach Progress in cardiovascular diseases 63 (3), 219-227, 2020 | 69 | 2020 |
| What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? M Banach, PE Penson Cardiovascular Research 115 (3), e26-e31, 2019 | 69 | 2019 |
Maciej BanachVice-Rector for Faculty of Medicine, KUL; President, International Lipid Expert Panel, PolandEmail verificata su umed.lodz.pl